CIPO Patents = 1

EPO Patents = 2

Forward Citations = 2

Loading Chart...

5 inventors (with patents filed for the assignee):

Delphine Charvin (3 out of 3 patents)

François Conquet (3 out of 3 patents)

Baptiste Manteau (2 out of 5 patents)

4. Vincent Pomel (2 out of 22 patents)

5. Justin Potnick (1 out of 13 patents)

6. Francois Conquet (0 patent)

4 patents: Sort by Forward Citations

1. 10532057 - Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia (2020-01-14),

2. 10442818 - Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptors (2019-10-15),

3. 10059671 - Positive allosteric modulators of mGluR3 (2018-08-28),

4. 10017521 - Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptors (2018-07-10),

Prexton Therapeutics Sa is a clinical-stage biopharmaceutical company focused on developing novel treatments for Parkinson's disease. With a pipeline of innovative targeted therapies, Prexton is dedicated to improving the lives of patients suffering from neurological disorders. The company's approach combines cutting-edge research with a commitment to delivering effective and safe treatments for Parkinson's disease and related conditions. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#13 in Plan les Ouates

#1,948 in Switzerland

Plan les Ouates, Switzerland

Prexton Therapeutics Sa

Forward Citations = 2

5 inventors:

Delphine Charvin (3 out of 3 patents)

François Conquet (3 out of 3 patents)

Baptiste Manteau (2 out of 5 patents)

4. Vincent Pomel (2 out of 22 patents)

5. Justin Potnick (1 out of 13 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com